Commentary · 11 Nov 2022
EditorialPublished 28 Jul 2021
Designated Medication Innovation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The second Proteome - Designated Medication Revelation Highest point will join enormous pharma and inventive biotech, just as key assessment pioneers in scholarly world, to foster powerful primary and biochemical instruments to open up the full helpful open door held inside the whole proteome. Recognize and approve novel druggable destinations and enhance structuredirected part based medication plan of little atoms with further developed power, selectivity, and physic-compound properties. With about 85% of the proteome as of now undrugged, getting to these objectives that are, as of now, incredibly hard to tranquilize, has kept analysts from accomplishing wanted clinical victories.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 23 Sep 2024
An Innovative Reversed Phase High-performance Liquid hromatography (Rp-hplc) Technique Designed for Concurrent Estimation Pertaining to Nebivolol Hydrochloride in Conjunction With Hydrochlorothiazide During Pharma-relate
Article · 5 Sep 2025
Medicinal Chemistry: Designing Molecules for Therapeutic Innovation
Opinion · 28 Mar 2025
Innovations in Randomized Trials: Exploring Adaptive Designs, Digital Integration and Evolving Methodologies
Article · 4 Mar 2025
Innovations in Clinical Trial Design to Improve Bioequivalence Assessments for Complex Generics
More from this journal
The newest in Journal of Biomedical and Pharmaceutical Sciences.
Brief report · 30 Nov 2025
iPSCs: Transforming Medicine Through Personalized Research
Article · 29 Nov 2025
Mechanisms of Cancer Drug Resistance and Overcoming Them
Article · 29 Nov 2025
Tumor Microenvironment: Key to Cancer Progression and Therapy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biomedical and Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Xiang-Hai ai”

